“Race and infant mortality in Northeast Ohio” forum moderated by Brie Zeltner, Plain Dealer Sept 27, 2017

“Race and infant mortality in NE Ohio:
why are black babies dying more and what can be done”

Wednesday September 27, 2017
moderated by: Brie Zeltner, The Plain Dealer
Heights Library Main Branch
2345 Lee Road 44118
7-8:30 p.m. Free & Open to the Public

Event link here   Event flyer here   Preview story

The video is here

Panelists:
Christin Farmer, Executive Director, Birthing Beautiful Communities

Kentra Harris, Parent/Mother and Client

Dr. Arthur R. James, The Ohio State Univ., Interim Exec Director Kirwin Institute, Nationwide Children’s Hospital (Cancelled)

Angela Newman White, Supervisor, Maternal and Child Health Program, Cuyahoga County Board of Health

Moderator:
Brie Zeltner, Reporter, The Plain Dealer


Brie Zeltner, Plain Dealer

Co-sponsored by the Case Western Reserve University Siegal Lifelong Learning Program, League of Women Voters-Greater Cleveland, Cleveland.com plus Cleveland Hts/University Hts Library System

Corporate sponsor: First Interstate Properties, Ltd.
For more information, email: teachingcleveland@earthlink.net

Henry Goldblatt, Developer of the Goldbatt Kidney : Mt Sinai Collection

The link is here

Goldblatt clamps for hypertension experiments, 1934

clamps_goldblatt-detail
Goldblatt’s clamps, one shown in placement tool.
Below instruments used to operate clamps.
clamps_goldgbatt-tools

Harry Goldblatt (1891-1977) received his M.D. from McGill University Medical School in 1916. He began a surgical residency, but when the U.S. entered the war he enlisted in the medical reserves of the U.S. army. He was sent to France and later Germany as an orthopedic specialist. He returned to Cleveland in 1924 as assistant professor of pathology at Western Reserve University School of Medicine, and in 1954 was appointed Professor of Experimental Pathology. In 1961 he was named emeritus, but in the same year was appointed director of the Louis D. Beaumont Memorial Research Laboratories at Mt. Sinai. He worked there until he retired in 1976. He died January 6, 1977.

Goldblatt’s interest in hypertension, sparked during his days as a surgical resident, eventually would lead to his international fame. During his early days in pathology, he noted persons with normal blood pressure who had systemic atherosclerosis (colloquially referred to as hardening of the arteries) that did not affect the kidney, and conversely patients with hypertension where arteriosclerosis was confined to the renal arteries. He had been taught that so-called benign essential hypertension was defined as persistent elevation of the blood pressure of unknown etiology, without significant impairment of the renal functions, and that the elevated blood pressure comes first and results in vascular sclerosis. In some cases renal damage does occur and may eventually lead to uremia. Goldblatt’s own observations; however, led him to believe that vascular sclerosis came first, followed by elevated blood pressure.

Testing this theory was difficult however, because Goldblatt did not know how to reproduce vascular sclerosis. He decided that simulating the results of obliterative renal vascular disease by constricting the arteries leading to the kidneys would be sufficient. In order to achieve constriction of the renal arteries, Goldblatt developed the clamps seen in the picture. His experiments using the clamps, performed on dogs, showed an increase in hypertension with no renal impairments. One of the earliest, unexpected findings was the constriction of one renal artery resulted in temporary elevation of blood pressure which returned to normal when the clamp was removed. Subsequent experiments by Goldblatt and others revealed that the constriction of the renal arteries causes a chemical chain reaction leading to hypertension. Renin, a substance released by the kidneys, is generated when the renal arteries are constricted. Renin in the bloodstream causes the production of angiotensin 1. Angiotensin 1 is benign until it reacts with the angiotensin converting enzyme (ACE) to become angiotensin 2, which is a major cause of hypertension.

Goldblatt, HarrryThe clamps built by Goldblatt initiated a chain reaction as well. Successive experiments and discoveries eventually led to the isolation of an ACE inhibitor. By preventing angiotensin 1 from becoming angiotensin 2, this inhibitor has reduced the risk of stroke, heart attack, and heart failure in many hypertension patients.

Goldblatt received many honors, most importantly the scientific achievement award of the A.M.A. in 1976. Because of the implications of his work, the American Heart Association established the Dr. Harry Goldblatt Fellowship. In 1957, to commemorate the 25 th anniversary of Goldblatt’s first successful experiment to induce arterial hypertension by renal ischemia in the dog, the University of Michigan held a conference on the basic mechanism of arterial hypertension at Ann Arbor. It was here that the confusion regarding the names of the various compounds was settled, and a universal nomenclature for angiotensin was accepted.

A forum discussion about healthcare in Northeast Ohio 1/16/2016

A forum discussion about healthcare in Northeast Ohio


Panelists (from left to right in video):
Sarah Hackenbracht, Executive Director, Cuyahoga Health Access Partnership
Dr. Todd Zeiger, Vice President, Primary Care Institute, University Hospitals
Heather Thiltgen, Senior VP, Medical Mutual

Moderator: Casey Ross, Healthcare Reporter, The Plain Dealer

Tuesday January 19, 2016 7-8:30pm
CWRU Siegal Facility in Beachwood, Ohio
This panel was consumer oriented and focused on accessing and affording health care at a time of rapid change in the industry–all with a Northeast Ohio focus. The panelists talked about changes in the way Cleveland area doctors are providing care and getting paid for care and how this affects patients.

The event cosponsors:
Case Western Reserve University Siegal Lifelong Learning Program, League of Women Voters-Greater Cleveland, Northeast Ohio Media Group

Corporate sponsor: First Interstate Properties, Ltd.

“How Reform is Changing Healthcare in Northeast Ohio: a Panel Discussion” (Video)

The video is here

“WHAT’S HONEST AND WHAT’S HYPE?”: HOW THE AFFORDABLE HEALTHCARE ACT
AND OTHER REFORMS WILL CHANGE HEALTHCARE IN NORTHEAST OHIO

March 19, 2014

Panel members include:
Dr. Eric Bieber, President, University Hospitals Accountable Care Organization
Dr. Akram Boutros, President and Chief Executive Officer, The MetroHealth System
Martin Hauser, Chief Executive Officer, SummaCare
Dr. David Longworth, Chairman of Medicine Institute, Cleveland Clinic
Moderated by Eileen Korey, former medical journalist

Presented by: 
CWRU Siegal Lifelong Learning, Teaching Cleveland Digital, and Cleveland Jewish News Foundation

Medicine in Cleveland by Diane Solov

Diane Solov is Program Manager of Better Health Greater Cleveland, a multi-stakeholder alliance dedicated to improving the quality of health care for people in Northeast Ohio with chronic illness. Based at Case Western Reserve University’s Center for Health Care Research and Policy at MetroHealth Medical Center, Solov manages the day-to-day operations of all aspects of the program.

Solov came to MetroHealth in March 2007 following a career in journalism, winning numerous awards and recognition for her work. She spent her last 15 years as a journalist at The Plain Dealer, Cleveland’s daily newspaper, as a medical editor, and previously, as a medical reporter. For nearly a decade, Solov often broke and edited stories about Northeast Ohio’s expansive health care market and national health care issues that affected them and their patients.

Solov earned a B.A. in anthropology from the University of Missouri and completed coursework in the M.A. program at its renowned School of Journalism. She was a 2010 Fellow of the Robert Wood Johnson Foundation’s Ladder to Leadership program.

The link is here